83 related articles for article (PubMed ID: 25040002)
1. TMPRSS2 Met160Val polymorphism: significant association with sporadic prostate cancer, but not with latent prostate cancer in Japanese men.
Maekawa S; Suzuki M; Arai T; Suzuki M; Kato M; Morikawa T; Kasuya Y; Kume H; Kitamura T; Homma Y
Int J Urol; 2014 Dec; 21(12):1234-8. PubMed ID: 25040002
[TBL] [Abstract][Full Text] [Related]
2. Met160Val polymorphism in the TRMPSS2 gene and risk of prostate cancer in a population-based case-control study.
Lubieniecka JM; Cheteri MK; Stanford JL; Ostrander EA
Prostate; 2004 Jun; 59(4):357-9. PubMed ID: 15065083
[TBL] [Abstract][Full Text] [Related]
3. Association of rs6983561 polymorphism at 8q24 with prostate cancer mortality in a Japanese population.
Suzuki M; Liu M; Kurosaki T; Suzuki M; Arai T; Sawabe M; Kasuya Y; Kato M; Fujimura T; Fukuhara H; Enomoto Y; Nishimatsu H; Ishikawa A; Kume H; Homma Y; Kitamura T
Clin Genitourin Cancer; 2011 Sep; 9(1):46-52. PubMed ID: 21700508
[TBL] [Abstract][Full Text] [Related]
4. Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160Val.
Giri VN; Ruth K; Hughes L; Uzzo RG; Chen DY; Boorjian SA; Viterbo R; Rebbeck TR
BJU Int; 2011 Feb; 107(3):466-70. PubMed ID: 20735386
[TBL] [Abstract][Full Text] [Related]
5. Association of lipoprotein lipase gene polymorphism with risk of prostate cancer in a Japanese population.
Narita S; Tsuchiya N; Wang L; Matsuura S; Ohyama C; Satoh S; Sato K; Ogawa O; Habuchi T; Kato T
Int J Cancer; 2004 Dec; 112(5):872-6. PubMed ID: 15386377
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
[TBL] [Abstract][Full Text] [Related]
7. Significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population.
Goto T; Nakano M; Ito S; Ehara H; Yamamoto N; Deguchi T
Urology; 2007 Jul; 70(1):127-30. PubMed ID: 17656222
[TBL] [Abstract][Full Text] [Related]
8. Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer.
Fukuda H; Tsuchiya N; Narita S; Kumazawa T; Horikawa Y; Inoue T; Saito M; Yuasa T; Matsuura S; Satoh S; Ogawa O; Habuchi T
Oncol Rep; 2007 Nov; 18(5):1155-63. PubMed ID: 17914566
[TBL] [Abstract][Full Text] [Related]
9. HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer.
Yokomizo A; Koga H; Kinukawa N; Tsukamoto T; Hirao Y; Akaza H; Mori M; Naito S
Prostate; 2004 Nov; 61(3):248-52. PubMed ID: 15368467
[TBL] [Abstract][Full Text] [Related]
10. Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.
Takahashi H; Lu W; Watanabe M; Katoh T; Furusato M; Tsukino H; Nakao H; Sudo A; Suzuki H; Akakura K; Ikemoto I; Asano K; Ito T; Wakui S; Muto T; Hano H
Int J Cancer; 2003 Nov; 107(2):224-8. PubMed ID: 12949798
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer.
Dos Reis ST; Pontes J; Villanova FE; Borra PM; Antunes AA; Dall'oglio MF; Srougi M; Leite KR
J Urol; 2009 May; 181(5):2320-5. PubMed ID: 19303106
[TBL] [Abstract][Full Text] [Related]
12. Association of SNP rs1447295 and microsatellite marker DG8S737 with familial prostate cancer and high grade disease.
Hamano T; Matsui H; Sekine Y; Ohtake N; Nakata S; Suzuki K
J Urol; 2010 Aug; 184(2):738-42. PubMed ID: 20639049
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of cytochrome P450 2B6 and prostate cancer risk: a significant association in a Japanese population.
Kurosaki T; Suzuki M; Enomoto Y; Arai T; Sawabe M; Hosoi T; Homma Y; Kitamura T
Int J Urol; 2009 Apr; 16(4):364-8. PubMed ID: 19425200
[TBL] [Abstract][Full Text] [Related]
14. The Val158Met polymorphism of the catechol-O-methyltransferase gene is not associated with the risk of sporadic or latent prostate cancer in Japanese men.
Suzuki M; Kurosaki T; Arai T; Sawabe M; Hosoi T; Kitamura T
Int J Urol; 2007 Sep; 14(9):800-4. PubMed ID: 17760745
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological significance of vitamin D receptor gene polymorphism for prostate cancer which is associated with a higher mortality in Japanese.
Hamasaki T; Inatomi H; Katoh T; Ikuyama T; Matsumoto T
Endocr J; 2001 Oct; 48(5):543-9. PubMed ID: 11789558
[TBL] [Abstract][Full Text] [Related]
16. Significance of vitamin D receptor gene polymorphism for prostate cancer risk in Japanese.
Watanabe M; Fukutome K; Murata M; Uemura H; Kubota Y; Kawamura J; Yatani R
Anticancer Res; 1999; 19(5C):4511-4. PubMed ID: 10650802
[TBL] [Abstract][Full Text] [Related]
17. -160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer.
Jonsson BA; Adami HO; Hägglund M; Bergh A; Göransson I; Stattin P; Wiklund F; Grönberg H
Int J Cancer; 2004 Apr; 109(3):348-52. PubMed ID: 14961571
[TBL] [Abstract][Full Text] [Related]
18. Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population.
Li Z; Habuchi T; Mitsumori K; Kamoto T; Kinoshitu H; Segawa T; Ogawa O; Kato T
J Urol; 2003 Jun; 169(6):2378-81. PubMed ID: 12771801
[TBL] [Abstract][Full Text] [Related]
19. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
[TBL] [Abstract][Full Text] [Related]
20. H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer.
Lindmark F; Zheng SL; Wiklund F; Bensen J; Bälter KA; Chang B; Hedelin M; Clark J; Stattin P; Meyers DA; Adami HO; Isaacs W; Grönberg H; Xu J
J Natl Cancer Inst; 2004 Aug; 96(16):1248-54. PubMed ID: 15316060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
